Financials
- Market Capitalization 1.1 B
- Employee 70
- Founded 1995
- CEO N/A
- Website www.savarapharma.com
- Headquarter Delaware, United States
- FIGI BBG000MS0823
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-10.62
Fiyat/satışlar oranı
-10.99 K
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2376 | KURA Kura Oncology, Inc. - Common Stock | 12.75 USD | +0.79% | -6.18% | +41.35% | +59.57% | 1.13 B USD | ||
| 2379 | JANX Janux Therapeutics, Inc. - Common Stock | 18.51 USD | +1.59% | -2.48% | +21.46% | -19.03% | 1.13 B USD | ||
| 2415 | SLDB Solid Biosciences Inc. - Common Stock | 9.77 USD | +1.98% | +1.03% | +23.20% | +71.40% | 1.05 B USD | ||
| 2423 | AVTX Avalo Therapeutics, Inc. - Common Stock | 19.26 USD | -0.41% | -2.18% | +5.48% | +107.99% | 1.03 B USD |